BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suassuna PGDA, de Paula RB, Sanders-pinheiro H, Moe OW, Hu M. Fibroblast growth factor 21 in chronic kidney disease. J Nephrol 2019;32:365-77. [DOI: 10.1007/s40620-018-0550-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Chang L, Chu C, Huang C, Lin L. Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus. Front Endocrinol 2022;13:846018. [DOI: 10.3389/fendo.2022.846018] [Reference Citation Analysis]
2 Zhang R, Cai X, Du Y, Liu L, Han X, Liu W, Gong S, Zhou X, Wang X, Wen X, Ji L. Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes. J Diabetes Complications 2021;35:107750. [PMID: 33097385 DOI: 10.1016/j.jdiacomp.2020.107750] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Maines E, Catesini G, Boenzi S, Mosca A, Candusso M, Dello Strologo L, Martinelli D, Maiorana A, Liguori A, Olivieri G, Taurisano R, Piemonte F, Rizzo C, Spada M, Dionisi-Vici C. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia. J Inherit Metab Dis 2020;43:1173-85. [PMID: 32681732 DOI: 10.1002/jimd.12287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Stamenov N, Kotov G, Iliev A, Landzhov B, Kirkov V, Stanchev S. Mast cells and basic fibroblast growth factor in physiological aging of rat heart and kidney. Biotechnic & Histochemistry. [DOI: 10.1080/10520295.2021.2024251] [Reference Citation Analysis]
5 Mantovani A, Zusi C, Dalbeni A, Grani G, Buzzetti E. Risk of Kidney Dysfunction IN Nafld. CPD 2020;26:1045-61. [DOI: 10.2174/1381612825666191026113119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gould PW, Zemel BS, Taratuta EG, Baker JF. Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning. J Rheumatol 2021;48:504-12. [PMID: 33132219 DOI: 10.3899/jrheum.200673] [Reference Citation Analysis]
7 Marchelek-Mysliwiec M, Dziedziejko V, Dolegowka K, Pawlik A, Safranow K, Stepniewska J, Wisniewska M, Malyszko J, Ciechanowski K. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease. J Appl Biomed 2020;18:61-9. [PMID: 34907727 DOI: 10.32725/jab.2020.005] [Reference Citation Analysis]
8 Chiu L, Wang C, Lin Y, Hsu B. Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.05.007] [Reference Citation Analysis]
9 Wu YT, Hsu BG, Wang CH, Lin YL, Lai YH, Kuo CH. Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients. Int J Environ Res Public Health 2020;17:E1938. [PMID: 32188054 DOI: 10.3390/ijerph17061938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tao QR, Chu YM, Wei L, Tu C, Han YY. Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review). Mol Med Rep 2021;23:260. [PMID: 33655322 DOI: 10.3892/mmr.2021.11899] [Reference Citation Analysis]
11 Salgado JV, Goes MA, Salgado Filho N. FGF21 and Chronic Kidney Disease. Metabolism 2021;118:154738. [PMID: 33617873 DOI: 10.1016/j.metabol.2021.154738] [Reference Citation Analysis]
12 Sarkar S, Chen S, Spencer B, Situ X, Afkarian M, Matsukuma K, Corwin MT, Wang G. Non-Alcoholic Steatohepatitis Severity Associates with FGF21 Level and Kidney Glucose Uptake. Metab Syndr Relat Disord 2021;19:491-7. [PMID: 34448598 DOI: 10.1089/met.2021.0055] [Reference Citation Analysis]
13 Gamrot Z, Adamczyk P, Świętochowska E, Roszkowska-Bjanid D, Gamrot J, Szczepańska M. Fibroblast growth factor 21 (FGF21) in children and adolescents with chronic kidney disease. Physiol Res 2020;69:451-60. [PMID: 32469231 DOI: 10.33549/physiolres.934307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu Q, Wang S, Wei M, Huang X, Cheng Y, Shao Y, Xia P, Zhong M, Liu S, Zhang G, Hu S. Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy. Front Endocrinol (Lausanne) 2019;10:566. [PMID: 31543863 DOI: 10.3389/fendo.2019.00566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Bolignano D, Greco M, Arcidiacono V, Tripolino O, Vita C, Provenzano M, Donato C, Chiarella S, Fuiano G, De Sarro G, Russo E, Andreucci M, Foti DP, Coppolino G. Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients. J Nephrol 2021;34:451-8. [PMID: 32656749 DOI: 10.1007/s40620-020-00801-5] [Reference Citation Analysis]
16 Fang H, Ghosh S, Sims LC, Stone KP, Hill CM, Spires D, Ilatovskaya DV, Morrison CD, Gettys TW, Stadler K. FGF21 prevents low-protein diet-induced renal inflammation in aged mice. Am J Physiol Renal Physiol 2021;321:F356-68. [PMID: 34151592 DOI: 10.1152/ajprenal.00107.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Zhang R, Li Y, Zhou X, Zhang F, Li M, Zhang S, Zhang X, Wen X, Ji L. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort. Medicine (Baltimore) 2021;100:e28238. [PMID: 34918690 DOI: 10.1097/MD.0000000000028238] [Reference Citation Analysis]
18 Mendoza LD, Hyndman KA. The contribution of collecting duct NOS1 to the concentrating mechanisms in male and female mice. Am J Physiol Renal Physiol 2019;317:F547-59. [PMID: 31241990 DOI: 10.1152/ajprenal.00180.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Chen Q, Ma J, Yang X, Li Q, Lin Z, Gong F. SIRT1 Mediates Effects of FGF21 to Ameliorate Cisplatin-Induced Acute Kidney Injury. Front Pharmacol 2020;11:241. [DOI: 10.3389/fphar.2020.00241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Su X, Kong Y, Peng D. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clin Chim Acta 2019;498:30-7. [PMID: 31419414 DOI: 10.1016/j.cca.2019.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Chiu L, Hung C, Lin L, Lin Y, Hsu B, D'elia L. Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis. International Journal of Hypertension 2022;2022:1-8. [DOI: 10.1155/2022/7098458] [Reference Citation Analysis]
22 Kondo Y, Komaba H, Fukagawa M. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease. Expert Rev Mol Diagn 2020;20:715-24. [PMID: 32513031 DOI: 10.1080/14737159.2020.1780918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]